Niagen Bioscience, Inc. (NAGE) Tops Q2 EPS by 2c

Niagen Bioscience, Inc. (NASDAQ: NAGE) reported Q2 EPS of $0.04, $0.02 better than the analyst estimate of $0.02. Revenue for the quarter came in at $31.1 million versus the consensus estimate of $28.36 million.

For earnings history and earnings-related data on Niagen Bioscience, Inc. (NAGE) click here.

You May Also Be Interested In

• Flutter Entertainment (FLUT) Reiterated at Market Outperform by Citizens
• Goldman Sachs: 'Our estimates for ANET, FFIV, and CLS 3Q26E are largely unchanged'
• Western Digital (WDC) call put ratio 1.1 calls to 1 put into Micron (MU) quarter results